CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
基本信息
- 批准号:6836493
- 负责人:
- 金额:$ 33.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-01-01 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresisSalmonella infectionsbacteria infection mechanismbacterial antigensbacterial geneticsbactericidal immunitybiomarkercellular immunityenzyme linked immunosorbent assayflow cytometrygenetic mappinggenetic strainhelper T lymphocytelaboratory mousephagocytosisvesicle /vacuolevirulence
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Salmonella, Mycobacterium
and Histoplasma are facultative intracellular pathogens that live inside
phagosomes of host macrophages. They all cause AIDS-defining illnesses, and the
investigator's long-term goal is to understand the development of immunity
against such pathogens. CD4+ T cells are also required for immune mice to
resist virulent Salmonella, providing a model of protective host functions
which can successfully combat a macrophage-tropic infection. However, the
specific bacterial antigens (Ags) recognized by Salmonella-immune hosts are
largely unknown. Two proteins expressed in the surface-exposed "compartment" of
Salmonella are recognized by CD4+ T cells from immune mice. One is a flagellar
protein also recognized by T cells from humans immunized with Salmonella. The
other is an unidentified protein expressed by most Enterobacteriaceae,
including E. coli, Yersinia, Shigella, and Enterobacter. Both proteins are
regulated in a fashion suggesting part of the Salmonella intracellular survival
strategy is to down-regulate expression of bacterial surface Ags recognized by
CD4+ T cells. In AIM I, the diversity of Salmonella Ags recognized by CD4+ T
cells from immune mice will be determined using SDS-PAGE fractionated bacteria
as Ag, and bacterial expression of these Ags will be characterized with respect
to compartmentalization and regulation using T cell clones. The studies will
provide insight into the nature of Ags recognized by CD4+ T cells, the
environmental signals affecting bacterial processing Salmonella for T cell
responses. In AIM 2, genes encoding Ags recognized by T cell clones will be
identified by expression cloning or sequencing analysis of biochemically
purified Ags. This work may reveal gene products useful as markers of cellular
immunity to Salmonella in humans. In AIM 3, murine infection with Salmonella
strains expressing a model Ag in various compartments of the bacterial cell
will be used to directly test if compartmentalization of bacterial Ag alters
its significance for surveillance by T cells. Primary and secondary CD4+ T cell
responses generated by these stains will be quantified using ELISPOT and flow
cytometry, and the effectiveness of an Ag-specific immune response against
these strains will be tested in vivo. These studies will provide insight into
the nature of Ags recognized by CD4+ T cells responding to pathogens similarly
adapted for life in phagosomes. In AIM 4, the functional importance of Ags
identified in AIMS 1 & 2 will be determined by testing purified Ags for their
ability to stimulate protective immunity against challenge by virulent
Salmonella. The protective Ags identified will be excellent candidates for
components of subunit vaccines and markers of cellular immunity in humans.
描述(改编自申请人的摘要):沙门氏菌,分枝杆菌
组织肿瘤是生活在内部的兼性细胞内病原体
宿主巨噬细胞的吞噬体。它们都导致定义疾病的艾滋病,以及
研究者的长期目标是了解免疫的发展
针对这种病原体。免疫小鼠也需要CD4+ T细胞
抵抗有毒的沙门氏菌,提供保护性宿主功能的模型
可以成功地抵抗巨噬细胞 - 授予感染。但是,
沙门氏菌免疫宿主识别的特定细菌抗原(AGS)是
在很大程度上未知。在表面暴露的“隔室”中表达的两种蛋白质
沙门氏菌被免疫小鼠的CD4+ T细胞识别。一个是鞭毛
蛋白质也被人类的T细胞识别,用沙门氏菌免疫。这
其他是大多数肠杆菌科表示的不明蛋白质,
包括大肠杆菌,Yersinia,Shigella和Enterobacter。两种蛋白质都是
以一种建议的一部分细胞内生存的方式调节
策略是下调由细菌表面AG的表达
CD4+ T细胞。在AIM I中,CD4+ T认可的沙门氏菌AG的多样性
免疫小鼠的细胞将使用SDS-PAGE分级细菌确定
作为Ag和这些AG的细菌表达将以尊重为特征
使用T细胞克隆分隔和调节。研究会
提供有关CD4+ T细胞识别的AG的性质的见解,
影响T细胞细菌加工沙门氏菌的环境信号
回答。在AIM 2中,编码由T细胞克隆识别的AG的基因将是
通过表达克隆或生化分析来鉴定
纯化的AGS。这项工作可能揭示了有用的基因产物作为细胞的标记
对人类沙门氏菌的免疫力。在AIM 3中,用沙门氏菌感染鼠类
在细菌细胞的各个隔室中表达AG模型的菌株
将用于直接测试细菌Ag的分室化是否改变
它对T细胞监视的重要性。初级和次级CD4+ T细胞
这些污渍产生的响应将使用ELISPOT和流量进行量化
细胞仪以及Ag特异性免疫反应的有效性
这些菌株将在体内进行测试。这些研究将提供有关
CD4+ T细胞识别的AG的性质类似地对病原体反应
适应吞噬体中的生命。在AIM 4中,AGS的功能重要性
在目标1和2中确定的将通过测试纯化的AGS确定其
通过有毒的能力刺激保护性免疫免受挑战的能力
沙门氏菌。确定的保护性AG将是出色的候选人
人类亚基疫苗和细胞免疫标记的成分。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis.
- DOI:10.1371/journal.ppat.0030161
- 发表时间:2007-11
- 期刊:
- 影响因子:6.7
- 作者:Bergsbaken T;Cookson BT
- 通讯作者:Cookson BT
Biogenesis of bacterial membrane vesicles.
- DOI:10.1111/j.1365-2958.2009.06731.x
- 发表时间:2009-06
- 期刊:
- 影响因子:3.6
- 作者:Deatherage BL;Lara JC;Bergsbaken T;Rassoulian Barrett SL;Lara S;Cookson BT
- 通讯作者:Cookson BT
Pyroptosis: host cell death and inflammation.
- DOI:10.1038/nrmicro2070
- 发表时间:2009-02
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRAD T COOKSON其他文献
BRAD T COOKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRAD T COOKSON', 18)}}的其他基金
Caliper Life Sciences IVIS Lumina II imaging system
Caliper 生命科学 IVIS Lumina II 成像系统
- 批准号:
8246848 - 财政年份:2012
- 资助金额:
$ 33.81万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
8236985 - 财政年份:2011
- 资助金额:
$ 33.81万 - 项目类别:
Immune Correlates and Mechanisms of Controlling NTS Bacteremia
免疫相关性和控制 NTS 菌血症的机制
- 批准号:
8026709 - 财政年份:2010
- 资助金额:
$ 33.81万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
7675881 - 财政年份:2009
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6285611 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6488760 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6691702 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6626383 - 财政年份:2001
- 资助金额:
$ 33.81万 - 项目类别:
相似国自然基金
GPR31b调控CX3CR1+巨噬细胞-RORγt+细胞轴抵御沙门氏菌感染的作用及机制研究
- 批准号:82300650
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道树突状细胞的MyD88信号在调控肠道抗菌肽RegIIIγ/β表达抗鼠伤寒沙门氏菌感染中的作用及机制研究
- 批准号:82301993
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
铁调控肉鸡肠道沙门氏菌感染进程的机制研究
- 批准号:32372919
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
月桂氮卓酮抗沙门氏菌感染的靶点及分子机制研究
- 批准号:32373066
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于调控巨噬细胞极化的母乳源植物乳杆菌胞外多糖抑制鼠伤寒沙门氏菌感染仔鼠的机制
- 批准号:32360026
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Microbial Effects on Epithelial Ubiquitination Pathways
微生物对上皮泛素化途径的影响
- 批准号:
7077627 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别:
Microbial Effects on Epithelial Ubiquitination Pathways
微生物对上皮泛素化途径的影响
- 批准号:
6935386 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别:
Microbial Effects on Epithelial Ubiquitination Pathways
微生物对上皮泛素化途径的影响
- 批准号:
6812111 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别: